According to filings with the U.S. Securities and Exchange Commission, S4 Medical is raising $7,762,026.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, William Fuller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About S4 Medical
S4 Medical is committed to developing solutions for safer and more effective catheter ablation treatment for atrial fibrillation. AF is an epidemic. Approximately 33 million people worldwide are living with AF, and 1 million Americans each year are diagnosed with the condition. With a worldwide aging population, these numbers will continue to grow for decades. S4’s esolution device is a patented technology intended to safely deviate and protect the esophagus. Designed by a team of physicians including electrophysiologists, cardiac anesthesiologists, and gastroenterologists, esolution is the only device that holds promise to protect the esophagus during catheter ablation. esolution was designed for bilateral and variable deflection and intended to accommodate each patient’s pulmonary vein anatomy. This flexibility aspires to allow the electrophysiologist to Ablate With Confidence.

To learn more about S4 Medical, visit http://s4medical.com/

Contact:
William Fuller, Chief Executive Officer
440-279-8091

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.